نتائج البحث - "E. Togliardi"

1

4CPS-188 Galenic preparations and rare diseases: guanidinoacetate methyltransferase deficiency: experience in a local hospital

المؤلفون: E Togliardi, L Gambitta, G Lo Cricchio, A Bezzi, E Strada, D Di Benedetto, L Zampogna

المصدر: Section 4: Clinical Pharmacy Services.

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, business.industry, Medical record, Guanidinoacetate methyltransferase deficiency, Ornithine, Creatine, medicine.disease, Guanidinoacetate N-methyltransferase, chemistry.chemical_compound, Regimen, chemistry, Quality of life, Metabolic control analysis, Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::83af802326c0112f764d02d9c9eb2458
https://doi.org/10.1136/ejhpharm-2019-eahpconf.337

View record in OpenAIRE

2

5PSQ-065 Manic symptomatology induced by alectinib: a case report

المؤلفون: L Ventura, L Gambitta, D Di Benedetto, E Togliardi, A Grecchi, G Lo Cricchio, L Zampogna

المصدر: Section 5: Patient Safety and Quality Assurance.

مصطلحات موضوعية: Alectinib, Olanzapine, Pediatrics, medicine.medical_specialty, Crizotinib, business.industry, Medical record, Lorazepam, Pharmacovigilance, medicine, Delirium, Aripiprazole, medicine.symptom, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a888b45216253a0456ece681de892b33
https://doi.org/10.1136/ejhpharm-2019-eahpconf.498

View record in OpenAIRE

3

Academic Journal

An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer

المؤلفون: A. Necchi, D. Raggi, P. Giannatempo, G. Pelosi, F.G. De Braud, S. Lo Vullo, L. Mariani, G. Calareso, E. Togliardi, F. Crippa, N. Di Genova, F. Perrone, M. Colecchia, B. Paolini, N. Nicolai, G. Procopio, R. Salvioni

المساهمون: A. Necchi, S. Lo Vullo, L. Mariani, D. Raggi, P. Giannatempo, G. Calareso, E. Togliardi, F. Crippa, N. Di Genova, F. Perrone, M. Colecchia, B. Paolini, G. Pelosi, N. Nicolai, G. Procopio, R. Salvioni, F.G. De Braud

مصطلحات موضوعية: alisertib, aurora A kinase, bladder cancer, salvage therapy, urothelial carcinoma, pharmacology, pharmacology (medical), oncology, Settore MED/06 - Oncologia Medica

Relation: info:eu-repo/semantics/altIdentifier/pmid/26873642; info:eu-repo/semantics/altIdentifier/wos/WOS:000372280400012; volume:34; issue:2; firstpage:236; lastpage:242; numberofpages:7; journal:INVESTIGATIONAL NEW DRUGS; http://hdl.handle.net/2434/442438; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84961052380

الاتاحة: http://hdl.handle.net/2434/442438
https://doi.org/10.1007/s10637-016-0328-9

View record in BASE

4

PS-033 Ifosfamide induced encephalopathy: prophylaxis and therapy with methylene blue

المؤلفون: S Nurro, L Gambitta, E. Togliardi, C Della Costanza, R Cusmai, E Ruffino, G. Saibene

المصدر: Patient safety and risk management.

مصطلحات موضوعية: Chemotherapy, Ifosfamide, Side effect, business.industry, medicine.medical_treatment, Encephalopathy, medicine.disease, Anesthesia, medicine, Antidote, Rhabdomyosarcoma, Adverse effect, business, medicine.drug, Mesna

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d642988cf5da4f298c4cefae375a8a5e
https://doi.org/10.1136/ejhpharm-2017-000640.539

View record in OpenAIRE

5

CP-123 A cost effectiveness analysis of nivolumab compared with pemetrexed for the treatment of non-small cell lung cancer in real practice

المؤلفون: V Di Mauro, C Della Costanza, B Re, R Cusmai, E. Togliardi, R. Langella, V Gentile, M Galassi, G. Antonacci, FA Langella

المصدر: Clinical pharmacy.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, education.field_of_study, business.industry, Population, Retrospective cohort study, medicine.disease, Surgery, Pemetrexed, Internal medicine, Expanded access, medicine, Progression-free survival, Nivolumab, Lung cancer, business, education, Incremental cost-effectiveness ratio, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bb6f288539006b9971b71e5f20e4e2c6
https://doi.org/10.1136/ejhpharm-2017-000640.122

View record in OpenAIRE

6

Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for muscle-invasive urothelial bladder cancer (MIUBC): Final results and translational findings of an open-label, single-arm, phase 2 study

المؤلفون: A. Necchi, S. Lo Vullo, D. Raggi, P. Giannatempo, N. Nicolai, L. Piva, D. Biasoni, M. Catanzaro, T. Torelli, S. Stagni, G. Calareso, E. Togliardi, M. Colecchia, A. Busico, F. Perrone, M. Pennati, N. Zaffaroni, L. Mariani, R. Salvioni

المصدر: European Urology Supplements. 16:e293-e294

مصطلحات موضوعية: Urology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::42b9d70b6811dcbdc75d3844fed1eb04
https://doi.org/10.1016/s1569-9056(17)30240-3

View record in OpenAIRE

7

Academic Journal

PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer : an open label, single-group, phase 2 trial

المؤلفون: A. Necchi, P. Giannatempo, E. Farè, D. Raggi, PENNATI, MARZIA, E. Togliardi, F. De Braud, L. Mariani, N. Zaffaroni, F. Crippa, A. Marchianò, N. Nicolai, M. Maffezzini, M. G. Daidone, A. M. Gianni, R. Salvioni

المساهمون: A. Necchi, P. Giannatempo, L. Mariani, E. Farè, D. Raggi, M. Pennati, N. Zaffaroni, F. Crippa, A. Marchianò, N. Nicolai, M. Maffezzini, E. Togliardi, M.G. Daidone, A.M. Gianni, R. Salvioni, F. De Braud

مصطلحات موضوعية: Activin Receptors, Type II, Aged, Angiogenesis Inhibitor, Antibodies, Monoclonal, Female, Human, Male, Middle Aged, Urologic Neoplasms, Settore MED/06 - Oncologia Medica

Relation: info:eu-repo/semantics/altIdentifier/pmid/24566706; info:eu-repo/semantics/altIdentifier/wos/WOS:000337084000019; volume:32; issue:3; firstpage:555; lastpage:560; numberofpages:6; journal:INVESTIGATIONAL NEW DRUGS; http://hdl.handle.net/2434/425873; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84904616246

الاتاحة: http://hdl.handle.net/2434/425873
https://doi.org/10.1007/s10637-014-0074-9

View record in BASE